JPMorgan warns Unilever's McCormick deal may disappoint, citing execution risks and limited value creation.

Unilever's potential sale of its foods division to McCormick is seen by JPMorgan as neutral at best for value creation, with significant execution risks. The deal, structured as a reverse Morris Trust, would give Unilever shareholders shares in a new foods company, while Unilever receives about €12 billion in cash. JPMorgan highlights tax costs and lost efficiencies totaling around €13 billion, outweighing synergies of €4 billion. The transaction also leaves Unilever with a smaller balance sheet, limiting future acquisition potential amid market uncertainties. Timing is a concern as Unilever recently completed a major restructuring, making the deal potentially disappointing for investors.